Reviva Pharmaceuticals (@RevivaPharma) header
Reviva Pharmaceuticals (@RevivaPharma) profile picture

We are a clinical-stage pharmaceutical company focused on developing novel therapies for CNS, respiratory, and metabolic diseases of huge unmet need.

Cupertino, CA
Joined April 2023
Photo by Reviva Pharmaceuticals (@RevivaPharma)Photo by Reviva Pharmaceuticals (@RevivaPharma)Photo by Reviva Pharmaceuticals (@RevivaPharma)Photo by Reviva Pharmaceuticals (@RevivaPharma)Photo by Reviva Pharmaceuticals (@RevivaPharma)Photo by Reviva Pharmaceuticals (@RevivaPharma)Photo by Reviva Pharmaceuticals (@RevivaPharma)Photo by Reviva Pharmaceuticals (@RevivaPharma)Photo by Reviva Pharmaceuticals (@RevivaPharma)Photo by Reviva Pharmaceuticals (@RevivaPharma)
Reviva Pharmaceuticals retweeted
$RVPH: @RevivaPharma FDA Feedback on New Formulation Imminent buff.ly/LWEY9xS by @vanjohn10
1
316
Reviva CEO Laxminarayan Bhat, Ph.D., presented at the Lytham Partners Fall 2026 Investor Conference, highlighting brilaroxazine’s Phase 3 and long-term data, proposed formulation, and path toward an NDA submission. Watch the full presentation here youtube.com/watch?v=IIaTT66n… $RVPH
191
Reviva Pharmaceuticals Founder, President & CEO, Laxminarayan Bhat, Ph.D., will be attending #BIO2026 June 22-25. Looking forward to connecting with leaders across the biotech and biopharma industries. Learn more: convention.bio.org/about-bio $RVPH
1
529
Founder & CEO Laxminarayan Bhat, Ph.D. recently participated in a company webcast presentation at the @LythamIR Spring 2026 Investor Conference. Watch the replay here: youtu.be/GWSvrgl0dzc?si=mqP6… $RVPH
1
573
Reviva Pharmaceuticals retweeted
See our extended interview with @RevivaPharma's CEO Dr Bhat. #brilaroxazine #schizophrenia $RVPH youtu.be/euVZhOVrtdg
1
3
5
781
Reviva Pharmaceuticals retweeted
$RVPH @RevivaPharma First Quarter 2026 Results buff.ly/kRcDKBX by @vanjohn10
1
1
1
342
Reviva Pharmaceuticals retweeted
Replying to @RevivaPharma
@RevivaPharma CEO Dr Laxminarayan Bhat talks with us about brilaroxazine's #ADHD indication & how it relates to other behavioral disorders. $RVPH #schizophrenia #biopharma #biotech youtube.com/shorts/0JkwB-YKt…
1
1
1,065
Reviva Pharmaceuticals retweeted
Replying to @RevivaPharma
@RevivaPharma CEO Dr Laxminarayan Bhat discusses the vocal biomarker that was developed in the RECOVER trial. $RVPH #schizophrenia #biopharma #biotech youtu.be/vngRvpKDGZ8
1
1
365
Reviva Pharmaceuticals retweeted
Replying to @RevivaPharma
@RevivaPharma CEO Dr Laxminarayan Bhat describes the trial design for RECOVER 2 which will evaluate schizophrenia patients with a four week regimen of brilaroxazine at 30 and 50 mg. $RVPH #schizophrenia #biopharma #biotech youtube.com/shorts/8SoS4jYPT…
2
1
3
788
Reviva Pharmaceuticals retweeted
Replying to @RevivaPharma
@RevivaPharma CEO Dr Laxminarayan Bhat looks ahead to other indications for brilaroxazine and what their market potential may be. $RVPH #schizophrenia #biopharma #biotech youtube.com/shorts/IE5ZxiLfm…
1
1
2
809
Reviva Pharmaceuticals retweeted
Replying to @RevivaPharma
@RevivaPharma CEO Dr Laxminarayan Bhat explains why most trials evaluating new atypical antipsychotics begin with schizophrenia and then pursue other indications in major depressive disorder and bipolar disorder later. #schizophrenia #biopharma #biotech youtube.com/shorts/-ugVYnRt4…
1
1
2
316
Reviva Pharmaceuticals retweeted
Replying to @RevivaPharma
@RevivaPharma expects to use a reformulation of brilaroxazine in its RECOVER 2 trial. CEO Dr Laxminarayan Bhat identifies the three changes that will be made to extend and strengthen the patent. #schizophrenia #biopharma #biotech youtube.com/shorts/-m8rPNmfY…
2
1
356